TXG
10x Genomics, Inc.
Nasdaq Laboratory Analytical Instruments Large accelerated filer

Key Financials

Net Income
$-43544000
↑ 76.2%
Operating Income
$-60985000
↑ 68.7%
Revenue
$642.8M
↑ 5.2%
Gross Profit
$443.9M
↑ 7.1%
EPS (Diluted)
$-0.35
↑ 77.0%
Total Assets
$1.0B
↑ 13.4%
Total Liabilities
$245.0M
↑ 17.5%
Cash & Equivalents
$344.1M
↓ 4.2%

Recent SEC Filings

Form Type Filed Date Link
4 6/24/2026 View on SEC
4 6/18/2026 View on SEC
144 6/16/2026 View on SEC
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
8-K 6/8/2026 View on SEC

Company Information

Field Value
Ticker TXG
Company Name 10x Genomics, Inc.
CIK 1770787
Sector Laboratory Analytical Instruments
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 3826
SIC Description Laboratory Analytical Instruments
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (925) 401-7300